Abstract
The incidence of mycotic infection due to yeasts has increased during the last few years because of the immunosuppressive therapies, prolonged antibiotic therapy, organ transplantations, aggressive instrumentations in medicine, AIDS, etc.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
J.R. Graybill, J.N. Galgiani, J.M. Jorgensen and D.A.Strandberg, Ketoconazole therapy for fungal urinary tract infections, J.Urol., 129: 68 (1983).
R. Guinet, J. Chanas, A. Coullier, G. Bonnefoy and P. Ambroise-Thomas, Fatal septisemia due to amphotericin B resistant Candida lusitaniae, J. Clin. Microbiol., 18: 443 (1983).
R.J. Holt and A. Azmi, Miconazole resistant Candida, Lancet, 1: 50 (1978).
E.M. Johnson, M.D. Richard and D.N. Warnock, In vitro resistance to imidazole antifungals in Candida albicans, J. Antimicrob. Chemother., 13: 547 (1984).
R.F. Boyd and B.G. Hoerl, The pathogenic fungi, in “Basic Medi- cal Microbiology”, R.F. Boyd, ed., pp 775–813; Little, Brown and Company; Boston (1986).
P.D. Hoeprich and M.G. Rinaldi, Candidosis, in “Infectious Diseases”, P.D. Hoeprich, ed., pp 436–450, Harper and Row Publisher, Philadelphia (1983).
D. Kerridge and R.D. Nicholas, Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata, J.Antimicrob. Chemother., Supp. B, 18: 39 (1986).
M.R. Mc Ginnis and M.G. Rinaldi, Antifungal drugs: Mechanisms of action, drug resistance, susceptibility testing and assays of activity in biological fluids, in: “Antibiotics in Laboratory Medicine”, Second Edition, V. Lorian, ed., Williams and Wilkins, Baltimore (1986)
J.N. Galgiani, J. Reiser et al., Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods, Antimicrob. Agents Chemother., 31: 1343 (1987).
S.P. Clissold and J.V. Cutsem, Overview of the antimicrobial activity of ketoconazole, in: “Ketoconazole Today”, H.E. Jones, ed., pp. 1–18, ADIS Press Limited, Manchester (1987).
D.J. Drutz, Newer antifungal agents and their use, including an update on amphotericin B and flucytosine, in: “Current Clinical Topics in Infectious Disease”, J.S. Remington and M.N. Swartz, eds., pp 97–135, Mc Graw-Hill Book Company, New York (1982).
S.Shadomy and A. Espinel-Ingroff and R.Y. Cartwright, Laboratory studies with antifungal agents: Susceptibility test and bioassays, in: “Manual of Clinical Microbiology”, E.H. Lennette, ed., pp. 991–999, American Society for Microbiology, Washington D.C. (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Johansson, C.B., Bilgin, S., Taşçioǧlu, J., Söyletir, G., Ener, B. (1991). In Vitro Activities of Nine Antifungal Agents on Candida Species Isolated as Causative Agents from Clinical Materials. In: Tümbay, E., Seeliger, H.P.R., Anǧ, Ö. (eds) Candida and Candidamycosis. Federation of European Microbiological Societies Symposium Series, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5910-4_40
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5910-4_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5912-8
Online ISBN: 978-1-4684-5910-4
eBook Packages: Springer Book Archive